The Year 2023 in Review

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Average (ratings)

No ratings

•

Your rating

In this week's Parallax podcast, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.

Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.

Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year’s most impactful trials:

•    ORBITA-2 (AHA Scientific Sessions): PCI for stable angina
•    FIRE (ESC Congress): Functional versus culprit-only revascularization in elderly patients with myocardial infarction and multivessel disease
•    DAPA-MI (AHA Scientific Sessions): SGLT2i in MI without diabetes or heart failure
•    ILUMIEN IV (ESC Congress): OCT vs angiography-guided PCI
•    OCTOBER (ESC Congress): OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
•    ARTESIA (ESC Congress): Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
•    SELECT (AHA Scientific Sessions): Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

What are the most impactful cardiovascular trials of 2023? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?

Catch the video version with slides by clicking here.

Read MoreRead Less

Audio Video

Episodes

Up Next

EP 106: Transforming Health Systems Through Economics with Dr Alex Carter

EP106 • Jan 29, 2024 • 47m 1s

The podcast embarks on an exploration of the program's three fundamental pillars: health economics, outcomes measurement, and management. Dr. Carter underscores the importance of efficiently allocating scarce resources, evaluating health system performance through population outcomes, and translating theoretical knowledge into practical application through leadership.

All Episodes

Ep 151: Cardiology's 2025 Year in Review with Dr Sukh Nijjer

EP151 • Jan 16, 2026 • 1h 40m 44s

In this highly anticipated annual year-end episode of Parallax, Dr Ankur Kalra welcomes back Dr Sukh Nijjer, an interventional cardiologist in London, for their seventh consecutive year reviewing cardiology's most significant developments.

Ep 150: Building a Legacy in Cardiology: From the NIH to JAMA Cardiology with Robert Bonow

EP150 • Jan 05, 2026 • 50m 44s

In this landmark 150th episode of Parallax marking the start of Season 8, Dr Ankur Kalra welcomes Professor Robert Bonow, Professor of Medicine and Cardiology at Northwestern University and Editor-in-Chief of JAMA Cardiology. This milestone conversation explores the career of one of cardiology's most influential academic leaders and examines how strategic vision, mentorship, and institutional leadership have shaped modern cardiovascular medicine.

Ep 149: The Placebo-Controlled Revolution: Redefining Evidence in Device Trials

EP149 • Dec 19, 2025 • 33m 7s

In this week's episode of Parallax, Dr Ankur Kalra welcomes Prof Rasha Al-Lamee, interventional cardiology consultant and professor of medicine/cardiology at Imperial College London, and deputy editor of JACC. Prof Al-Lamee has transformed interventional cardiology through her pioneering work on the ORBITA trial series and coronary sinus reducer device studies, introducing the paradigm-shifting concept of sham-controlled device trials to the field.

Ep 148: Breaking Down Healthcare Borders: Five Pillars to Revolutionary Access

EP148 • Dec 08, 2025 • 32m 30s

In this episode of Parallax, Dr Ankur Kalra welcomes Dr Sarah Matt, Associate Clinical Professor at Upstate Medical University, health tech strategist, and author of the newly released The Borderless Healthcare Revolution.

Ep 147: From Landfill to Life-Saving: GOMED's Mission to Reimagine Medical Device Distribution

EP147 • Nov 24, 2025 • 38m 44s

In this week's episode of Parallax, Dr Ankur Kalra welcomes Dr Courtney Maxey-Jones, Director of the Coronary Care Unit at Upstate University Hospital and a cardiac anesthesiologist intensivist by training. Dr Maxey-Jones co-founded and serves as Chief Operations Officer of GOMED, a not-for-profit organization transforming how we think about medical device waste and global healthcare equity.

Ep 146: The Heart Function Revolution: Why Prevention Matters at Every Stage of Disease

EP146 • Nov 10, 2025 • 37m 49s

In the latest episode of Parallax, Dr Ankur Kalra welcomes Dr Martha Gulati and Dr Anu Lala for a groundbreaking conversation about reimagining heart failure prevention across the entire disease spectrum.

Ep 145: From NAFLD to MASLD: Unveiling the Cardiovascular Impact of Metabolic Liver Disease

EP145 • Oct 24, 2025 • 30m 36s

In this essential episode of Parallax, Dr Ankur Kalra welcomes Dr Monica Tincopa for a crucial conversation about Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its profound implications for cardiovascular care.

Ep 144: ESC 25 in Review with Dr Purvi Parwani

EP144 • Oct 13, 2025 • 1h 5m 25s

In this evidence-packed episode of Parallax, Dr Ankur Kalra welcomes back Dr Purvi Parwani for a comprehensive review of groundbreaking trials presented at the European Society of Cardiology Congress.

Ep 143: GDMT Optimisation: Mitigating SCD Risk and Addressing Women’s Cardiac Health

EP143 • Sep 29, 2025 • 43m 45s

In this episode of Parallax, Dr Ankur Kalra speaks with Dr Benjamin A D’Souza, Associate Professor of Medicine at the University of Pennsylvania and Section Chief of Cardiac Electrophysiology at Presbyterian Medical Center. Together, they explore the challenges of mitigating sudden cardiac death and the evolving role of guideline-directed medical therapy in optimising patient outcomes.

Ep 142: The Psychology of Patient Care: Nudges, Gamification, and the Future of Cardiology

EP142 • Sep 08, 2025 • 30m 38s

In this fascinating episode of Parallax, Dr Ankur Kalra sits down with Dr Alexander Fanaroff, who provides cutting-edge insights from behavioural economics to transform how we approach patient care and clinical decision-making.